A SOLID ORAL PHARMACEUTICAL FORMULATION OF ENZALUTAMIDE

DOP2026000073AUndetermined Publication Date: 2026-06-15BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
DO · DO
Patent Type
Applications
Current Assignee / Owner
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
Filing Date
2026-03-18
Publication Date
2026-06-15
Patent Text Reader

Abstract

The present invention relates to a novel oral solid pharmaceutical formulation of enzalutamide or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable excipients. The present invention provides a pharmaceutical formulation of enzalutamide comprising one or more pharmaceutically acceptable polymers. Furthermore, the present invention also provides an improved process for preparing the oral solid pharmaceutical formulation of enzalutamide.
Need to check novelty before this filing date? Find Prior Art